Abstract 3324: Optimizing the therapeutic potential of tyrosine kinase inhibitors in chemo-immunotherapy of B-cell acute lymphoblastic leukemia involving rituximab
Krzysztof Domka(Medical University of Warsaw), Małgorzata Firczuk(Medical University of Warsaw), Beata Krzymieniewska(Instytut Hematologii i Transfuzjologi), Karolina Siudakowska(Medical University of Warsaw), Zuzanna Urbańska(Medical University of Lodz), Bartosz Perkowski(Medical University of Silesia), Łukasz Sędek(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Martyna Poprzeczko(Medical University of Warsaw), Łukasz Komorowski(Polish Academy of Sciences), Klaudyna Fidyt(Polish Academy of Sciences), Magdalena Winiarska(Medical University of Warsaw), Agata Pastorczak(Medical University of Lodz), Mieszko Lachota(Medical University of Warsaw), Agnieszka Dąbkowska(Medical University of Warsaw)
Cited by 1
Related Papers
<i>β</i>‐caryophyllene and <i>β</i>‐caryophyllene oxide—natural compounds of anticancer and analgesic properties
|Cancer Medicine|2016|642
The KMT2A recombinome of acute leukemias in 2023
|Leukemia|2023|214